Conformationally Constrained Butyrophenones. Synthesis and Evaluation as Antipsychotics

$63.10 plus tax (Refund Policy)

Buy Article:

Abstract:

The present report provides a full and extended study of the chemistry and CNS pharmacology of cyclic aminobutyrophenones as neuroleptics. A series of more than fifty novel conformationally restricted aminobutyrophenones bearing 4-(6-fluorobenzisoxazol-3-yl)piperidine, 4-(4-fluorobenzoyl)piperidine, 4-phe-nylpiperazine, 4-(2-methoxyphenyl)piperazine, 4-(2-pyridyl)piperazine, or linear but-yro- phenone fragments have been prepared and evaluated as antipsychotic agents by in vitro assays of affinity for dopamine (D1, D2 and, in some cases, D4) and serotonin (5-HT2A, 5-HT2B and 5-HT2C) receptors, and by in vivo assays on antipsychotic potential and extrapyramidal side effects. The synthesized amino-butyrophenones are referred to as a-(2-aminoethyl) and b-(aminomethyl)-benzocycloalkanones in the benzene series, as well as a-(2-aminoethyl) and b-(amino methyl) heterocycloalkanones in the thiophene, furan, indole, carbazole and quinoline series. In all these series the conformation of the butyrophenone chain is constrained by its partial incorporation into a cycloalkanone ring fused to a benzene or heterocyclic ring. Most of the butyrophenones prepared are very active as atypical antipsychotic agents, and represent good candidates for a further development. Some butyrophenones bearing arylpiperazine moieties show selectivity at 5-HT2B 5-HT2C receptors.
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more